OLUSEUN OSINOWO: Open Payments
NPI 1548614431 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 18 payments from 3 companies in 2025. Trend: 2023 $1,013 · 2024 $560 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $280 |
| Otsuka America Pharmaceutical, Inc. | 6 | $155 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: INGREZZA, REXULTI, CAPLYTA.
Industry payments across IL — which companies pay providers there.
